![](https://sdbig.com/wp-content/uploads/2023/10/medium-BVxZ4C.jpeg)
Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound.
San Diego Black Investors Group
Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound.